Venolife, gel, 40g

Composition

>

of 100 g of gel contains:  

active ingredients:

troxerutin 2 g,

dexpanthenol 5 g and sodium heparin 0.25 g (30,000 units);

excipients:

phenylethyl alcohol,

propylene glycol,

carbomer 940 or 980,

trometamol,

purified water.

Pharmacological action

Venolife gel is a combined preparation for external use, the pharmacological properties of which are determined by the action of its constituent substances. Heparin-a direct-acting anticoagulant, a natural anticoagulant factor of the body-has an anti-inflammatory effect, promotes the regeneration of connective tissue by inhibiting the activity of hyaluronidase; prevents thrombosis, activates the fibrinolytic properties of blood; improves local blood flow.

Dexpanthenol-provitamin B 5-in the skin is converted into pantothenic acid, which is part of coenzyme A, which plays an important role in the processes of acetylation and oxidation; improving metabolic processes, dexpanthenol promotes the regeneration of damaged tissues; improves the absorption of heparin. Troxerutin is an angioprotective agent; it has P-vitamin activity, in particular, it reduces vascular-tissue permeability and capillary fragility, promotes normalization of microcirculation and tissue trophism, reduces congestion in veins and paravenous tissues, has an anti-edematous and anti-inflammatory effect.

In addition, due to the presence of a preservative-antiseptic phenylethyl alcohol, the drug has a bactericidal and fungicidal effect, contributing to the prevention of infection of the wound surface. The composition of the gel base provides the drug with moderate hyperosmolar properties.

Indications

• edematous-pain syndrome and microcirculatory-trophic disorders caused by venous insufficiency of the lower extremities (varicose veins, acute and chronic thrombophlebitis, post-thrombophlebitis syndrome, chronic lymphostasis);
• soft tissue injuries (hematomas, dislocations, sprains);
• to accelerate granulation and epithelialization of trophic ulcers during the regeneration phase (in the absence of pronounced exudation).

Use during pregnancy and lactation

Venolife is not contraindicated during pregnancy and lactation.

Contraindications

Hypersensitivity to the components of Venolife; open infected wounds or wounds with heavy exudation.

Side effects

Local manifestations of allergic reactions (skin rash, pruritus) are possible.

How to take, course of use and dosage

Venolife is applied in a thin layer on the affected area and around it 2-3 times a day, evenly distributing over the skin surface with light rubbing movements until completely absorbed. The course of treatment is 2-3 weeks. The need for further treatment is determined by the attending physician, based on the severity of the pathological process and the results of clinical tests. If the disease recurs, the course of treatment can be carried out 2-3 times a year.

For trophic ulcers with weak exudation, before applying the drug, the wound surface is cleaned of exudate and necrotic tissues, if necessary, washed with a solution of hydrogen peroxide 3%, furacilin 1: 5000 or chlorhexidine bigluconate 0.05% and dried. The gel is applied evenly in a thin layer so that the entire affected surface is covered with the drug, and a sterile gauze dressing is applied. Bandages are changed once a day. With an open method of treatment, the drug is applied 1-2 times a day. The duration of treatment is determined by the dynamics of epithelialization.

Special instructions

Venolife is not intended for use in ophthalmology, for intravaginal and rectal use.

Form of production

Gel for external use.

Storage conditions

At a temperature of 15-25 °C

Shelf life

2 years

Active ingredient

Heparin sodium, Dexpanthenol, Troxerutin

Dosage form

gel for external use

Description

For pregnant women, Adults, and Nursing mothers

Indications

Swelling after injuries and operations, Bruises, Varicose Veins, Hematomas, Thrombophlebitis